Presidential Symposium: Big Ideas for Big Data

By Ahmar U. Zaidi, MD “In God we trust. All others must bring data.” The amount of data generated from the dawn of humanity until 2003 was 5 exabytes. Since then, 5 exabytes of data are created every two days. There is no doubt that our ability to collect and store...

One-Size-Fits-All for AML? Not Anymore

By Ilana Yurkiewicz, MD Once upon a time, there was “7+3.” Developed in the 1970s, this easy-to-remember induction chemotherapy regimen for acute myeloid leukemia (AML) went largely unchanged for decades. But in the past few years, we have seen multiple new drug...

Mission (Im)Possible

By Binod Dhakal, MD, MS The year 1982 heralds the discovery of the first mutated genes to be identified in cancer, RAS. The three RAS genes — KRAS, NRAS, and HRAS — still constitute the most frequently mutated oncogene family in human cancers. However, despite more...

Update on Precision Medicine Initiatives

Applying the principles of precision medicine to hematologic diseases is a priority for ASH. Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of...